abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2007년 3월 14일

저자:
Associated Press

Abbott Laboratories won't introduce new drugs in Thailand due to breaking of patent

...Abbott Laboratories said it has decided not to launch new medicines in Thailand in response to the government's decision not to honor the company's patent for its AIDS-fighting drug [Kaletra]. "Thailand has revoked the patent on our medicine, ignoring the patent system. Under these circumstances, we have elected not to introduce new medicines there," said Dirk Van Eeden, public affairs director of Abbott International...Activists accused Abbott of depriving poor people of lifesaving medications. "...I am horrified ... Abbott has the hubris to blacklist a courageous country like Thailand simply trying to do the right thing for its people," said Michael Weinstein, the president of the AIDS Healthcare Foundation...[also refers to Sanofi-Aventis and Bristol-Myers Squibb]